This conference has been withdrawn from the 2020 conference schedule
As you are aware, coronavirus is having a global impact and the World Health Organization and the Centers for Disease Control have instituted recommendations that include social distancing and cancelling conferences and large gatherings. Since safety of our attendees is always GRC's highest priority, the GRC Board of Trustees has decided to withdraw this conference and it will be rescheduled for 2022. This decision was made out of an abundance of caution and to alleviate the concerns of our conference communities that are scheduled to meet in this timeframe.
Fibroblast growth factor (FGF) signaling is an evolutionarily conserved cell-to-cell communication system that regulates nearly every aspect of embryonic development, as well as adult tissue homeostasis, tissue repair and metabolic physiology. Accordingly, aberrant FGF signaling is the cause of a variety of developmental disorders, metabolic dysfunction, age-related diseases and cancer. This conference will bring together academic scientists, clinicians and industry leaders with a common interest in FGF biology to share innovations that are impacting the field. The meeting's sessions will span a range of topics to reflect the diverse biological functions of FGF signaling and its downstream molecular effectors. These topics include embryonic development and organogenesis, musculoskeletal biology, neurobiology, endocrinology, cancer biology, molecular signaling and structural biology. Each session will entertain presentations by both renowned leaders and colleagues new to the FGF field with particular emphasis on balanced gender and geographical representation. Peer reviewed abstracts will also be considered for platform presentations. In addition to the main scientific program, ample time is available for informal networking to maximize interaction and facilitate collaborations between the meeting participants. Altogether, the meeting provides a unique opportunity to integrate a wide-range of perspectives on FGF biology in relation to human health and disease, with a view to understanding disease mechanisms and devising new therapeutic tools.